<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In this study we evaluated the safety/efficacy of citicoline in 30 patients affected by atherosclerotic processes with cerebral localization </plain></SENT>
<SENT sid="1" pm="."><plain>Aim of this study was to confirm, from a clinical point of view, the efficacy of citicoline in increasing blood flow in the vascular zone and in exerting a trophic action on cerebral cells improving the symptoms related to the <z:hpo ids='HP_0011010'>chronic</z:hpo> cerebrovasculopathy </plain></SENT>
<SENT sid="2" pm="."><plain>Therapeutic effect was evaluated, by means of subjective parameters, at the beginning, during and at the end of the study </plain></SENT>
<SENT sid="3" pm="."><plain>The results obtained was statistically analyzed confirming the efficacy of citicoline on the subjective symptomatology </plain></SENT>
<SENT sid="4" pm="."><plain>Safety was excellent in <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
</text></document>